Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
mRNA-1283 Dose Ranging Study in Children 6 Months to <12 Years
NCT07808697Phase 2Recruiting
- Sponsor
- Moderna Inc
- Start
- Sep 2026
- Primary completion
- Aug 2029
- Countries
- 6
01
Overview
A Phase 2 trial of mRNA-1283.251 in coronavirus disease 2019 (COVID-19), sponsored by Moderna Inc. Started Sep 2026; status: recruiting.
02
Drugs
mRNA-1283.251
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT07808697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07808697.